Home | | | Search | | | Browse | | | Resources | | | Help | | | What's New | | | About |
---|
Clinical Research Network in Non-alcoholic Steatohepatitis - Pediatric Trial
This study is not yet open for patient recruitment.
Sponsored by: | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
---|---|
Information provided by: | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
Purpose
To determine if therapeutic modification of insulin resistance or oxidative stress leads to improvement in serum or histologic indicators of liver injury or quality of life.
Condition | Treatment or Intervention | Phase |
---|---|---|
Fatty Liver |
Drug: Metformin Drug: Vitamin E Drug: Placebo |
Phase III |
MedlinePlus related topics: Liver Diseases
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study
Eligibility
Ages Eligible for Study: 8 Years - 15 Years, Genders Eligible for Study: Both
Criteria
Location Information
More Information
National Institute of Diabetes and Digestive and Kidney Diseases
U.S. National Library of Medicine, Contact NLM Customer Service | ||||||||||||||
National Institutes of Health, Department of Health & Human Services | ||||||||||||||
Copyright, Privacy, Accessibility, Freedom of Information Act |